Described are a compound of formula (II) or (III):
The compounds are effective in the treatment of disease, including a tauopathy condition or a disease of tau protein aggregation.
Described are a compound of formula (II) or (III):
The compounds are effective in the treatment of disease, including a tauopathy condition or a disease of tau protein aggregation.
所述化合物为式 (II) 或 (III):
这些化合物可有效治疗疾病,包括牛头蛋白病症或牛头蛋白聚集症。
3,6-DISUBSTITUTED XANTHYLIUM SALTS AS MEDICAMENTS
申请人:Wista Laboratories Ltd.
公开号:EP2373660A2
公开(公告)日:2011-10-12
US9549933B2
申请人:——
公开号:US9549933B2
公开(公告)日:2017-01-24
[EN] 3,6-DISUBSTITUTED XANTHYLIUM SALTS<br/>[FR] SELS DE XANTHYLIUM DISUBSTITUÉS EN 3 ET 6